Leiden

• Treatment of ELectroencephalographic STatus epilepticus After cardiopulmonary Resuscitation-2 (TELSTAR-2): a multicenter randomised clinical … Recruiting
  2024-516068-27-01 5 2025-04-10 status epilepticus
• Ivosidenib in participants with locally advanced or metastatic conventional chondrosarcoma untreated or previously treated with 1 or 2 syste … Recruiting
  2023-508507-20-00 5 2025-04-03 Locally advanced or metastatic conventional chondrosarcoma with an IDH
• Esketamine nasal spray (Spravato) for the treatment of therapy-resistant bipolar depression. An open-label pilot trial. Recruiting
  2023-508125-27-00 4 2025-04-01 Bipolar disorder- depressive episode
• Efficacy and safety of minidosing lysergic acid diethylamide (LSD) for chronic cluster headache: a randomized placebo-controlled study Recruiting
  2024-520305-39-00 4 2025-04-01 Chronic cluster headache
• Clear-Brain: stimulating amyloid clearance in cerebral amyloid angiopathy Recruiting
  2023-506128-10-00 4 2025-03-27 Cerebral amyloid angiopathy
• The impact of vaccine platform, age and HIV infection on germinal centre formation. Recruiting
  2023-510354-16-00 11 2025-03-06 HIV infection
• Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1 Recruiting
  2023-509748-89-00 7 2025-02-19 Facioscapulohumeral muscular dystrophy (FSHD)
• A Phase 1/2 Dose-Exploration and Dose-Expansion Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients with Alpha-1 Antitry … Recruiting
  2023-509256-34-00 7 2025-02-06 Alpha-1 Antitrypsin Deficiency (AATD)-Associated Lung Disease and/or L
• A placebo-controlled, single-blind, phase I study in healthy volunteers and patients with Rheumatoid Arthritis with ABO21009 Recruiting
  2024-517547-31-00 1 2025-01-31 Rheumatoid Arthritis
• NEOAC Recruiting
  2024-516126-54-00 4 2025-01-21 ANAPLASTIC THYROID CANCER
• CHOPIN Recruiting
  2024-516127-14-01 7 2025-01-21 metastasized melonama uveal
• The effect of a booster vaccination on protection against the mpox virus: is a booster vaccination with a lower dose as effective as the sta … Recruiting
  2024-510697-24-00 10 2025-01-02 mpox (earlier: monkey pox)
• ACTME Recruiting
  2024-516125-31-02 9 2024-12-18 Metastatic Melanoma
• Safe Stop Trial Melanoma Recruiting
  2024-516937-10-01 5 2024-12-18 Melanoma
• A clinical trial to learn about the effects of YTB in people with difficult to treat active systemic lupus erythematosus (SLE), or active k … Recruiting
  2023-510150-17-00 4 2024-12-11 Active, refractory systemic lupus erythematosus (SLE), and active, re
• A clinical trial to learn about the effects of YTB323 in people with difficult to treat severe diffuse cutaneous systemic sclerosis (dcSSc) Recruiting
  2023-510380-34-00 4 2024-12-10 Diffuse cutaneous systemic sclerosis (dcSSc)
• Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting
  2024-513092-40-00 6 2024-12-05 Stroke
• Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study Recruiting
  2023-508558-25-01 9 2024-12-02 Type 1 Diabetes
• (WHAT!) – RCT: Open-label randomized controlled trial for the effects of continuous daily use of ethinylestradiol/levonorgestrel (30/150 µg/ … Recruiting
  2024-517127-40-00 11 2024-11-29 Migraine
• The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlle … Recruiting
  2024-514055-15-00 6 2024-11-19 Pulmonary sarcoidosis
• A Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohorts Study to Assess the Pharmacokinetics and Safety of Givinostat in DMD P … Recruiting
  2024-511823-32-00 4 2024-11-06 Duchenne muscular dystrophy (DMD)
• Active vitamin D for secondary hyperparathyroidism after bariatric surgery: a multicenter randomized controlled trial (ActiVitD) Recruiting
  2023-510312-40-00 6 2024-11-04 Secondary hyperparathyroidism
• A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides difficile Infection: The Re … Recruiting
  2022-502972-22-00 5 2024-10-31 Clostridioides difficile infection.
• Timing of start of systemlc treatment for asymptomatic MEtastasized PANcreatic cancer (TIMEPAN): a prospective multicenter patient preferenc … Recruiting
  2023-509465-20-00 5 2024-10-28 metastatic pancreatic cancer

Showing 145–168 of 459 trials